These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 19016740

  • 1. Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis.
    Zeis T, Probst A, Steck AJ, Stadelmann C, Brück W, Schaeren-Wiemers N.
    Brain Pathol; 2009 Jul; 19(3):459-66. PubMed ID: 19016740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W.
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.
    Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H.
    Brain; 2012 Mar; 135(Pt 3):886-99. PubMed ID: 22366799
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination.
    Pu A, Mishra MK, Dong Y, Ghorbanigazar S, Stephenson EL, Rawji KS, Silva C, Kitagawa H, Sawcer S, Yong VW.
    J Neuroinflammation; 2020 Jul 23; 17(1):220. PubMed ID: 32703234
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W.
    Glia; 1999 Oct 23; 28(1):34-9. PubMed ID: 10498820
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Longoni G, Brown RA, MomayyezSiahkal P, Elliott C, Narayanan S, Bar-Or A, Marrie RA, Yeh EA, Filippi M, Banwell B, Arnold DL, Canadian Pediatric Demyelinating Disease Network.
    Brain; 2017 May 01; 140(5):1300-1315. PubMed ID: 28334875
    [Abstract] [Full Text] [Related]

  • 16. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
    Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Nait Oumesmar B.
    Glia; 2013 Oct 01; 61(10):1659-72. PubMed ID: 23918253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 01; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.